Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2006-05-30
2006-05-30
Winkler, Ulrike (Department: 1648)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C435S005000
Reexamination Certificate
active
07052676
ABSTRACT:
Methods are provided for inhibiting or suppressing viral replication in an infected host cell. More specifically, methods are provided for inhibiting or suppressing viral replication in an infected host cell by administering compounds that interfere with the binding of C-X-C chemokines to C-X-C chemokine receptors. Such methods are advantageous for treating viral infections such as human immunodefeciency virus infections.
REFERENCES:
patent: 5965536 (1999-10-01), Cohen et al.
patent: 6140338 (2000-10-01), Naya et al.
patent: 2004/0022762 (2004-02-01), Dillon et al.
Murayama et al. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. Journal of Leukocyte Biology (1998) vol. 68, pp. 62-67.
Howard et al. Inhibition of in vitro and in vivo HIV replication by distamycin analogue that interferes with the chemokine receptor function: a candidate for chemotherapeutic and microbicidal application. Journal of Medicinal Chemistry (1998) vol. 41, pp.
“The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 are Potent Agonists for the Type, B, but Not the Type A, Human Interlukin-8 Receptor”, S.K. Ahuja et al., The Journal of Biological Chemistry, vol. 271, No. 34, Aug. 1996, pp. 20545-20550.
“CC CKR5: A Rantes, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1”, G. Alkhatib et al., SCIENCE, vol. 272, Jun. 28, 1996, pp. 1955-1958.
“HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α-dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication”, A. Amara et al., J. Exp. Med., The Rockefeller University Press, vol. 186, No. 1, Jul. 1997, pp. 139-146.
“Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells”, A. Anisowicz et al., Proc. Natl. Acad. Sci. USA, vol. 84, Oct. 1987, pp. 7188-7192.
“Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation” L. Arvanitakis et al., NATURE, vol. 385, Jan. 1997, pp. 347-349.
“Kaposi's Sarcoma in the Gambia, West Africa is Less Frequent in Human Immunodeficiency Virus Type 2 than in Human Immunodeficiency Virus Type 1 Infection Despite a High Prevalence of Human Herpesvirus 8”, K. Ariyoshi et al., Journal of Human Virology, vol. 1, No. 3, Mar./Apr. 1998, pp.; 193-199.
“Macrophage-dependent Apoptosis of CD4+T Lymphocytes from HIV-infected Individuals is Mediated by FasL and Tumor Necrosis Factor”, A. Badley et al., J. Exp. Med., The Rockefeller University Press, vol. 185, No. 1, Jan. 1997, pp. 55-64.
“G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogensis activator”, C. Bais et al., NATURE, vol. 391, Jan. 1998, pp. 86-69.
“The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence”, G. Barillari et al., Proc. Natl. Acad. Sci. USA, vol. 90, Sep. 1993, pp. 7941-7945.
“Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?”, V. Beral et al., The Lancet, Medical Science, vol. 335, Jan. 1990, pp. 123-128.
“The lymphocyte chemoattaractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry”, C. Bleul et al., NATURE, vol. 382, Aug. 1996, pp. 829-833.
“A Highly Efficacious Lymphocyte Chemoattractant, Stromal Cell-derived Factor 1 (SDF-1)”, C. Bleul et al., J. Exp. Med., The Rockefeller University Press, vol. 184, Sep. 1996, pp. 1101-1109.
“Induction of Interleukin-10 by Human Immunodeficiency Virus Type 1 and its gp120 Protein in Human Monocytes/Macrophages”, P. Borghi et al., Journal of Virology, Feb. 1995, pp. 1284-1287.
“Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells” C. Boshoff et al., Nature Medicine, vol. 1, No. 12, Dec. 1995, pp. 1274-1278.
“Kaposi's Sarcoma-Associated Herpesvirus”, C. Boshoff et al., Advances in Cancer Research, 1998, pp. 57-86.
“Clinical aspects of Kaposi's sarcoma”, A. Buchbinder, MD et al., Cancer in AIDS, 1992 Current Science ISSN, Current Opinion in Oncology 1992, vol. 4, pp. 867-874.
“Regulation of HIV-1 Expression by Cytokine Networks in a CD4+Model of Chronic Infection”, S. Butera et al., The Journal of Immunology, vol. 150, No. 2, Jan. 1993, pp. 625-634.
“Macrophage Inflammatory Protein-1α is Induced by Human Immunodeficiency Virus Infection of Monocyte-Derived Macrophages”, B. Canque et al.,BLOOD, vol. 87, No. 5, Mar. 1996, pp. 2011-2019.
“Inhibition of HIV Type 1 BaL Replication by MIP-1α, MIP-1β, and RANTES in Macrophages”, M. Capobianci et al., Aids Research and Human Retroviruses, vol. 14, Nov. 3, 1998, pp. 233-240.
“Identification of Herpesvirus-Like DNA Sequences in AIDS-Associated Kaposi's Sarcoma” Y. Chang et al., SCIENCE, vol. 266, Dec. 1994, pp. 1865-1869.
“The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates”, H. Choe et al., CELL, vol. 85, Jun. 1996, pp. 1135-1148.
“The HIV-1 gp120 Envelope Protein has the Intrinsic Capacity to Stimulate Monokine Secretion”, K. Clouse et al., The Journal of Immunology, vol. 147, No. 9, Nov. 1991, pp. 2892-2900.
“Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+T Cells”, F. Cocchi et al., SCIENCE, vol. 270, Dec. 1995, pp. 1811-1815.
“RANTES inhibits HIV-1 replication in human peripheral blood monocytes and alveolar macrophages”, M. Coffey et al., The American Physiological Society, 1997, pp. L1025-L1029.
“Change in Coreceptor Use Correlates with Disease Progression in HIV-1 Infected Individuals”, R. Connor et al., J. Exp. Med., The Rockefeller University Press, vol. 185, No. 4, Feb. 1997, pp. 621-628.
“Coordinate Enhancement of Cytokine Gene Expression in Human Immunodeficiency Virus Type 1-Infected Promonocytic Cells”, M. D'Addario et al., Journal of Virology, vol. 64, No. 12, Dec. 1990, pp. 6080-6089.
“Expression of Human Herpesvirus 8-Encoded Cyclin D in Kaposi's Sarcoma Spindle Cells”, M. Davis et al., Journal of the National Cancer Institute, vol. 89, No. 24, Dec. 1997, pp. 1868-1874.
“Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allete of the CKR5 Structural Gene”, M. Dean et al., SCIENCE, vol. 273, Sep. 1996, pp. 1856-1862.
“Identification of a major co-receptor for primary isolates of HIV-1”, H. Deng et al., NATURE, vol. 381, Jun. 1996, pp. 661-666.
“Dysregulation of Interleukin 8, Interleukin 10, and Interleukin 12 Release by Alveolar Macrophages from HIV Type 1-Infected Subjects”, M. Denis et al., AIDS Research and Human Retroviruses, vol. 10, Nov. 1994, pp. 1619-1627.
“Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTESβ-chemokines”, A. Dolei et al., AIDS 1998, vol. 12, No. 2 pp. 183-190.
“A Dual-Tropic Primary HIV-1 Isolate that Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3 and CKR-2b as Fusion Cofactors”, B. Doranz et al., Cell, vol. 85, Jun. 1996, pp. 1149-1158.
“HIV-1 entry into CD4+cells is mediated by the chemokine receptor CC-CKR-5”, T. Dragic et al., NATURE, vol. 381, Jun. 1996, pp. 667-673.
“Release, Uptake, and Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein on Cell Growth and Viral Transactivation”, B. Ensoli et al., Journal of Virology, Jan. 199
Lane Brian R.
Markovitz David M.
Polverini Peter J.
Strieter Robert M.
The Regents of the University of Michigan
Winkler Ulrike
LandOfFree
Methods for inhibition of HIV replication using a small... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibition of HIV replication using a small..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibition of HIV replication using a small... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3635601